• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未能识别或有效管理处方阿片类药物依赖成为一名外科患者使用海洛因——丁丙诺啡/纳洛酮治疗及康复的诱因。

Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use-buprenorphine/naloxone treatment and recovery in a surgical patient.

作者信息

Conroy Stephen, Hill Duncan

机构信息

Lanarkshire Alcohol and Drug Service, Coatbridge, Scotland, UK.

NHS Lanarkshire, Motherwell, Scotland, UK.

出版信息

BMJ Case Rep. 2014 Dec 17;2014:bcr2014207458. doi: 10.1136/bcr-2014-207458.

DOI:10.1136/bcr-2014-207458
PMID:25519865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4275746/
Abstract

The prescribing of opioid pain medication has increased markedly in recent years, with strong opioid dispensing increasing 18-fold in Tayside, Scotland since 1995. Despite this, little data is available to quantify the problem of opioid pain medication dependence (OPD) and until recently there was little guidance on best-practice treatment. We report the case of a young mother prescribed dihydrocodeine for postoperative pain relief who became opioid dependent. When her prescription was stopped without support, she briefly used heroin to overcome her withdrawal. After re-exposure to dihydrocodeine following surgery 9 years later and treatment with methadone for dependency, she was transferred to buprenorphine/naloxone. In our clinical experience and in agreement with Department of Health and Royal College of General Practitioner guidance, buprenorphine/naloxone is the preferred opioid substitution treatment for OPD. Our patient remains within her treatment programme and has returned to work on buprenorphine 16 mg/naloxone 4 mg in conjunction with social and psychological support.

摘要

近年来,阿片类止痛药物的处方量显著增加,自1995年以来,苏格兰泰赛德地区强效阿片类药物的配药量增加了18倍。尽管如此,几乎没有数据可用于量化阿片类止痛药物依赖(OPD)问题,而且直到最近,关于最佳治疗方法的指导也很少。我们报告了一例年轻母亲的病例,她因术后疼痛缓解而被开具双氢可待因,后来对阿片类药物产生了依赖。当她在没有支持的情况下停止用药时,她短暂地使用海洛因来克服戒断反应。9年后,她在手术后再次接触双氢可待因,并接受美沙酮治疗成瘾,之后转用丁丙诺啡/纳洛酮。根据我们的临床经验,并与卫生部和皇家全科医师学院的指导意见一致,丁丙诺啡/纳洛酮是治疗OPD的首选阿片类替代疗法。我们的患者仍在治疗方案中,并在社会和心理支持下,服用丁丙诺啡16毫克/纳洛酮4毫克恢复了工作。

相似文献

1
Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use-buprenorphine/naloxone treatment and recovery in a surgical patient.未能识别或有效管理处方阿片类药物依赖成为一名外科患者使用海洛因——丁丙诺啡/纳洛酮治疗及康复的诱因。
BMJ Case Rep. 2014 Dec 17;2014:bcr2014207458. doi: 10.1136/bcr-2014-207458.
2
Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone.初级保健中阿片类止痛药依赖的管理:使用丁丙诺啡/纳洛酮持续康复。
BMJ Case Rep. 2014 Nov 28;2014:bcr2014207308. doi: 10.1136/bcr-2014-207308.
3
Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.在接受丁丙诺啡/纳洛酮维持治疗的海洛因成瘾患者样本中,阿片类药物剂量适当性量表(ODAS)的效度和信度的证据。
Drug Alcohol Depend. 2018 Feb 1;183:127-133. doi: 10.1016/j.drugalcdep.2017.10.035. Epub 2017 Dec 11.
4
Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders.美沙酮-纳洛酮治疗对有海洛因和处方类阿片使用障碍的年轻成年人的反应不同。
Am J Addict. 2017 Dec;26(8):838-844. doi: 10.1111/ajad.12641. Epub 2017 Nov 16.
5
Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.未处方使用美沙酮和丁丙诺啡在阿片类药物替代治疗之前:在瑞典五个城市的阿片类药物依赖者中,终身流行率、动机和药物来源。
Harm Reduct J. 2019 May 2;16(1):31. doi: 10.1186/s12954-019-0301-y.
6
Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.丁丙诺啡/纳洛酮与美沙酮治疗阿片类药物依赖:一项纵向调查。
Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):871-4.
7
Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.在英国毒品战略框架下,通过医疗手段戒除阿片类药物依赖:美沙酮和丁丙诺啡-纳洛酮(苏立文)患者的比较。
J Subst Abuse Treat. 2013 Jan;44(1):97-102. doi: 10.1016/j.jsat.2012.04.003. Epub 2012 Jun 15.
8
Evaluation of buprenorphine dosage adequacy in opioid receptor agonist substitution therapy for heroin dependence: first use of the BUprenorphine-naloxone Dosage Adequacy eVAluation (BUDAVA) questionnaire.评估丁丙诺啡在海洛因依赖阿片受体激动剂替代治疗中的剂量充足性:BUprenorphine-naloxone Dosage Adequacy eVAluation(BUDAVA)问卷的首次应用。
Clin Drug Investig. 2012 Jul 1;32(7):427-32. doi: 10.2165/11633230-000000000-00000.
9
Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.丁丙诺啡 + 纳洛酮:新组合。阿片类药物依赖:无证据表明自我注射风险降低。
Prescrire Int. 2007 Dec;16(92):232-5.
10
Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.非依赖海洛因和依赖海洛因的恒河猴在海洛因与食物之间的选择:纳洛酮、丁丙诺啡和美沙酮的作用
J Pharmacol Exp Ther. 2006 May;317(2):711-23. doi: 10.1124/jpet.105.095380. Epub 2006 Feb 2.

引用本文的文献

1
Causation and Common Liability in the Progression of the U.S. Opioid Crisis.美国阿片类药物危机演变中的因果关系与共同责任
J Stud Alcohol Drugs. 2024 Jan;85(1):12-18. doi: 10.15288/jsad.23-00289. Epub 2023 Dec 11.
2
Peripherally administered cannabinoid receptor 2 (CBR) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG.在外周给予大麻素受体 2 (CBR) 激动剂会使 TRPV1 基因敲除小鼠失去抗痛觉过敏作用,而鞘内给予则会导致抗痛觉过敏,并减少背根神经节和脊髓中的 GFAP、CCL2 和 TRPV1 的表达。
Brain Res. 2022 Jan 1;1774:147721. doi: 10.1016/j.brainres.2021.147721. Epub 2021 Nov 10.
3
Development of Pharmacist Independent Prescribing Clinics to Treat Opioid Analgesic Dependence in NHS Lanarkshire.在北拉纳克郡国民保健服务体系中开展药剂师独立处方诊所治疗阿片类镇痛药依赖项目。
Pharmacy (Basel). 2019 Aug 22;7(3):119. doi: 10.3390/pharmacy7030119.
4
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.内源性大麻素水解抑制剂SA-57:在小鼠中的内在抗伤害感受作用、增强吗啡诱导的抗伤害感受以及减弱觅药行为。
Neuropharmacology. 2017 Mar 1;114:156-167. doi: 10.1016/j.neuropharm.2016.11.015. Epub 2016 Nov 25.
5
How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction.市面上含可待因的镇痛药对篡改的耐受性如何?评估阿片类药物提取的可能性。
Pain Ther. 2016 Dec;5(2):187-201. doi: 10.1007/s40122-016-0053-2. Epub 2016 Jun 13.

本文引用的文献

1
Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland.1995 - 2010年阿片类药物及其他镇痛药使用情况的变化:对苏格兰一大片地理区域人群的配药处方进行重复横断面分析。
Eur J Pain. 2015 Jan;19(1):59-66. doi: 10.1002/ejp.520. Epub 2014 May 8.
2
Chronic pain, addiction, and Zohydro.慢性疼痛、成瘾与羟考酮缓释片(Zohydro)
N Engl J Med. 2014 May 29;370(22):2061-3. doi: 10.1056/NEJMp1404181. Epub 2014 Apr 23.
3
Medication-assisted therapies--tackling the opioid-overdose epidemic.药物辅助治疗——应对阿片类药物过量流行问题
N Engl J Med. 2014 May 29;370(22):2063-6. doi: 10.1056/NEJMp1402780. Epub 2014 Apr 23.
4
Prescription opioid abuse in the UK.英国的处方阿片类药物滥用问题。
Br J Clin Pharmacol. 2013 Nov;76(5):823-4. doi: 10.1111/bcp.12133.
5
Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.基层医疗实践中的阿片类药物成瘾和滥用:美沙酮和丁丙诺啡作为治疗选择的比较。
J Natl Med Assoc. 2012 Jul-Aug;104(7-8):342-50. doi: 10.1016/s0027-9684(15)30175-9.
6
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.丁丙诺啡维持治疗与安慰剂或美沙酮维持治疗用于阿片类物质依赖的比较
Cochrane Database Syst Rev. 2008 Apr 16(2):CD002207. doi: 10.1002/14651858.CD002207.pub3.